Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patients affected by rheumatic diseases with special focus for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, systemic lupus erythematosus, systemic sclerosis, vasculitides, Sjogren syndrome, and crystal-induced arthritis.

Osteoporosis in Rheumatic Diseases

Adami, Giovanni;Fassio, Angelo;Rossini, Maurizio;Caimmi, Cristian;Giollo, Alessandro;Orsolini, Giovanni;Viapiana, Ombretta;Gatti, Davide
2019-01-01

Abstract

Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patients affected by rheumatic diseases with special focus for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, systemic lupus erythematosus, systemic sclerosis, vasculitides, Sjogren syndrome, and crystal-induced arthritis.
2019
arthritis
inflammation
osteoporosis
rheumatic diseases
rheumatology
Animals
Humans
Osteoporosis
Rheumatic Diseases
File in questo prodotto:
File Dimensione Formato  
ijms-20-05867-v2.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso ristretto
Dimensione 386.34 kB
Formato Adobe PDF
386.34 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1021572
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 73
  • ???jsp.display-item.citation.isi??? 66
social impact